AnodyneWiki

Sevoflurane

sevo
Sevoflurane
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass200.05 g/mol [1]
AppearanceLiquid [1]
Density1505 at 25 °C/D [1]
Melting point< 25 °C [1]
Boiling point58.5 °C [1]
SolubilityVery slightly soluble [1]
Predicted LogP2.8 [1]
Structural Identifiers
[]
Molecular formulaC4H3F7O
IUPAC name1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane
SMILESC(OC(C(F)(F)F)C(F)(F)F)F
InChIInChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2
InChIKeyDFEYYRMXOJXZRJ-UHFFFAOYSA-N
CAS number28523-86-6
UNII38LVP0K73A
PubChem CID5206
Pharmacokinetics[]
Elimination half-life15–23 hours
MetabolismLiver by CYP2E1
ExcretionKidney
Routes of administrationInhalation
Toxicity
[]
Rat:
- Rat) (A308) LC50: 49881 ppm/hr (Inhalation: 10.8 g/kg
 [1]

Sevoflurane (also known as Sevofluran, Ultane, Sevorane, Sevoflurano, Sojourn, sevoflo, Sevofluranum, Mr6s4, Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)- or Sevocalm) is a substance of the ether class.

Chemistry

 []

Sevoflurane is achiral.

Sevoflurane matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

The precise mechanism of action of sevoflurane has not been fully elucidated. Like other halogenated inhalational anesthetics, sevoflurane induces anesthesia by binding to ligand-gated ion channels and blocking CNS neurotransmission. It has been suggested that inhaled anesthetics enhance inhibitory postsynaptic channel activity by binding GABA<sub>A</sub> and glycine receptors, and inhibit excitatory synaptic channel activity by binding nicotinic acetylcholine, serotonin, and glutamate receptors. Sevoflurane has an effect on several ionic currents, including the hyperpolarisation-activated cation current (I<sub>f</sub>), the T-type and L-type Ca<sup>2+</sup> currents (I<sub>Ca, T</sub> and I<sub>Ca, L</sub>), the slowly activating delayed rectifier K<sup>+</sup> currents (I<sub>Ks</sub>), and the Na<sup>+</sup>/Ca<sup>2+</sup> exchange current (I<sub>NCX</sub>). This ability to modulate ion channel activity can also regulate cardiac excitability and contractility. [1]

Medical side effects []

127 side effects listed on drug labels in (sevoflurane).

  • Mental disorder
  • Anaphylactic shock
  • Anaphylactoid reaction
  • Bone disorder
  • Bronchospasm
  • Dermatitis contact
  • Dyspnoea
  • Oedema
  • Dermatitis
  • Rash
  • Body temperature increased
  • Gastrointestinal disorder
  • Cardiac arrest
  • Cardiac disorder
  • Hepatitis
  • Hyperkalaemia
  • Hypersensitivity
  • Immune system disorder
  • Jaundice
  • Renal failure acute
  • Mediastinal disorder
  • Muscle rigidity
  • Nervous system disorder
  • Pancreatitis
  • Pruritus
  • Renal failure
  • Rhabdomyolysis
  • Convulsion
  • Torsade de pointes
  • Tubulointerstitial nephritis
  • Urethral disorder
  • Urinary tract disorder
  • Urticaria
  • Ventricular fibrillation
  • Ventricular tachycardia
  • Wheezing
  • Hepatic failure
  • Hepatic function abnormal
  • Swelling face
  • Intracranial pressure increased
  • Hepatic necrosis
  • Electrocardiogram QT prolonged
  • Eyelid oedema
  • Malnutrition
  • Skin disorder
  • Muscle twitching
  • Respiratory depression
  • Pulmonary function test decreased
  • Chest pain
  • Chest discomfort
  • Hepatobiliary disease
  • Tonic clonic movements
  • Acidosis
  • Obstructive airways disorder
  • Albuminuria
  • Amblyopia
  • Apnoea
  • Arrhythmia
  • Asthenia
  • Atrial fibrillation
  • Confusional state
  • Feeling abnormal
  • Conjunctivitis
  • Cough
  • Cough increased
  • Dizziness
  • Syncope
  • Dysgeusia
  • Fluorosis
  • Glycosuria
  • Headache
  • Haemorrhage
  • Haemoglobin
  • Hiccups
  • Hyperbilirubinaemia
  • Hyperglycaemia
  • Hypertension
  • Hyperventilation
  • Hypotension
  • Body temperature decreased
  • Hypothermia
  • Laryngospasm
  • Leukocytosis
  • Hypertonia
  • Nausea
  • Nervousness
  • Tension
  • Oliguria
  • Pain
  • Pharyngitis
  • Supraventricular extrasystoles
  • Chills
  • Salivary hypersecretion
  • Stridor
  • Shock
  • Loss of consciousness
  • Tachycardia
  • Thrombocytopenia
  • Angiopathy
  • Vomiting
  • Dry mouth
  • Urinary retention
  • Arrhythmia supraventricular
  • Agitation
  • Hypophosphataemia
  • Atrioventricular block complete
  • Ventricular extrasystoles
  • Ventricular bigeminy
  • Liver function test abnormal
  • Dysuria
  • Sputum increased
  • Increased bronchial secretion
  • Urine abnormality
  • Urine analysis abnormal
  • Breath holding
  • Breath holding attack
  • Hypoxia
  • Hypoventilation
  • Extrasystoles
  • Atrioventricular block second degree
  • Bradycardia
  • Electrocardiogram ST segment depression
  • Electrocardiogram T wave inversion
  • Fluoride increased
  • Insomnia
  • Somnolence
  • Respiratory failure

Indications

  • Convulsion

 []

  • Australia: Sevoflurane is a Schedule 4.
  • Brazil: Sevoflurane is a C1.[3]
  • Canada: Sevoflurane is Prescription only.
  • United Kingdom: Sevoflurane is Prescription only.
  • United States: Sevoflurane is Prescription only.[4][5]
  • European Union: Sevoflurane is Prescription only.[6][7][8][9]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 5206, Sevoflurane. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5206
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Sevoflurane. UNII: 38LVP0K73A. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/38LVP0K73A
  3. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  4. Ultane- sevoflurane liquid. DailyMed. 18 August 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c9aa6489-5a36-44ed-9512-b996833d82f7
  5. Sojourn- sevoflurane liquid. DailyMed. 26 June 2024. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fedfd1db-7e32-44b2-89e9-7bb00ee6810d
  6. SevoFlo EPAR. European Medicines Agency. 14 August 2007. https://www.ema.europa.eu/en/medicines/veterinary/EPAR/sevoflo
  7. SevoFlo PI. Union Register of medicinal products. 13 December 2002. https://ec.europa.eu/health/documents/community-register/html/v035.htm
  8. Sevohale (previously known as Sevocalm) EPAR. European Medicines Agency. 29 July 2016. https://www.ema.europa.eu/en/medicines/veterinary/EPAR/sevohale-previously-known-sevocalm
  9. Sevohale PI. Union Register of medicinal products. 24 June 2016. https://ec.europa.eu/health/documents/community-register/html/v196.htm

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 20:00:21
drugspromissing (no DrugsPRO reagent data)2026-11-20 20:00:17
erowidmissing (no Erowid substance of that name)2026-11-20 20:00:17
gsrsok2026-11-20 20:00:17
hmdbmissing (hmdb.ca refused automated access to HMDB0015366)2026-11-20 20:00:17
keggok2026-11-20 20:00:19
pubchemok2026-11-20 20:00:17
redditmissing (no r/tripreports posts mention it)2026-11-20 20:00:17
siderok2026-11-20 20:00:17
structureok2026-11-20 20:00:17
wikipediaok2026-11-20 20:00:17